This suggests that in the setting of NSCLC with aberrant KEAP1-NRF2 pathway, increased SLC7A11 expression might empower tumors to evade CD8-IFNγ-induced ferroptosis. Here, KEAP1 is linked to non-small cell lung carcinoma.